Company

Secretome Therapeutics

https://secretometherapeutics.com/

Industryclinical-stage biotechnology company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC)

Funding raised

CompanyRoundDate
Secretome TherapeuticsSeries A2026-05-28
Secretome TherapeuticsFunding2024-11-25